100% hair restored: Arthritis drug proves efficacy, some patients report hair regrowth in trial
SMRTR summary
An arthritis drug called upadacitinib has shown strong results in treating severe alopecia areata, an autoimmune condition where the immune system attacks hair follicles. In two international trials, about half of patients achieved at least 80% scalp hair coverage after 24 weeks, with some reaching full regrowth, despite starting the trials having lost an average of 84% of their hair.
SMRTR provides this summary for quick context. The original article belongs to Interesting Engineering.
Read the original article